 |
인쇄하기
취소
|
Gleevec, a new medicine for leukemia, to be sold in June.
Designated as an orphan drug, Gleevec, the leukemia remedy of Novartis, is likely to be sold in June.
Having held a Central Medical Council on May 31, the Korea Food and Drug Administration (KFDA) formed a conclusion that Gleevec should be designated as an orphan drug.
According to this, KFDA is planning to designate Gleevec as an orphan drug early in June and Gleevec is expected to be p...
Having held a Central Medical Council on May 31, the Korea Food and Drug Administration (KFDA) formed a conclusion that Gleevec should be designated as an orphan drug.
According to this, KFDA is planning to designate Gleevec as an orphan drug early in June and Gleevec is expected to be p...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.